Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have two close blood relatives (such as a parent, sibling, or child) who have had pancreatic cancer, where at least one of those relatives is a direct (first-degree) relative of the person being considered
- People who carry a harmful change (mutation) in one of these genes — APC, BRCA1, MLH1, MSH2, MSH6, PMS2, EPCAM, PALB2, or TP53 — and who also have a close blood relative (first or second degree, such as a grandparent, aunt, or uncle) who has had pancreatic cancer
- People who carry a harmful mutation in one of these genes: CDKN2A/p16, STK11, PRSS1, SPINK1/PST1, CTRC, CPA1, ATM, or BRCA2
- People who meet the age requirements for pancreatic surveillance monitoring — generally age 50 or older, or at least 10 years younger than the youngest family member who developed pancreatic cancer (this age threshold may be lower for people with certain gene mutations, confirm with trial site)
- People aged 21 or older
- People who agree to be contacted for follow-up
- People who live in the United States
- People who have already completed an MRI scan with a specific imaging technique called MRCP, with no significant findings related to the pancreas (such as a pancreatic mass)
- People whose previous MRCP scan did not have metal-related image interference over the pancreas area
- People who are already scheduled for a procedure called an endoscopic ultrasound (a camera examination that looks at the pancreas from inside the digestive tract)
- People who have had at least one MRCP scan in the past three years, and who are also scheduled to have an endoscopic ultrasound on the same day as part of their regular monitoring
Who may not be able to join:
- People who have developed a new reason that makes MRI scanning unsafe for them (for example, having a new medical device implanted that is not safe for MRI use)
- People who have a history of claustrophobia (fear of enclosed spaces) or who needed medication to reduce anxiety during a previous MRI scan
- People who have had abdominal surgery in the past that could affect how the endoscopic ultrasound or MRI results are interpreted
- People who have a medical condition that would make the risks of anaesthesia too high
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard Kinh Gian Do, MD, PhD, Memorial Sloan Kettering Cancer Center
Phone: 212-639-8591
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Compare image quality of novel high-resolution magnetic resonance pancreas (MRP) to conventional MRCP
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.